---
title: "Three type birth-mutation-death process"
author: "Itziar Irurzun Arana"
date: "`r Sys.Date()`"
output:  
  prettydoc::html_pretty:
    theme: cayman 
    highlight: github
vignette: >
  %\VignetteIndexEntry{Three type birth-mutation-death process}
  %\VignetteEngine{knitr::rmarkdown}
  %\VignetteEncoding{UTF-8}
---

```{r setup, include = FALSE}
knitr::opts_chunk$set(
  collapse = TRUE,
  comment = "#>",
  warnings= FALSE
)
```
Let us consider the three-type birth-death process shown in Figure 2. This model is
extensively used in investigating the dynamics of tumor cells in response to treatment, where a population initially sensitive to therapy will gain resistance via mutation and expand at a different rate. In this example, the sensitive cell type (type 0, blue) is sensitive to both drugs A and B and proliferates and dies with rate b0 and d0 respectively. Type 0 cells are able to mutate to give two different cell types, type 1 (green) and 2 (orange) which will be resistant to one of the drugs. In this example the sensitive cell line being analyzed is the BT-20 cell line, the data is obtained from the HMS LINCS database and the drugs being evaluated are the small molecule kinase inhibitors dactolibib and trametinib. In the HMS LINCS database there is no information about resistant cell lines for these drugs, even so, we create the data to evaluate the dynamics of Type 1 (resistant to trametinib) and Type 2 (resistant to dactolisib) cells to show a more complete example of the type of analysis that can be conducted using ACESO.

![Figure 2. Three type branching process.](3type_branching.jpg)
Load libraries:
```{r}
library(ACESO)
library(ggplot2)
```

## Data
In the current evaluation cell viability data resulting from the exposure of BT-20 triple-negative breast cancer cell line  to different concentration values of two small molecule kinase inhibitors (Dactolisib and Trametinib) is analyzed.
```{r}
data(Alpelisib_Trametinib_combination)
head(Alpelisib_Trametinib_combination)

DrugA=as.character(Alpelisib_Trametinib_combination$Drug.Name[1])
DrugB=as.character(Alpelisib_Trametinib_combination$Drug2.Name[1])
print(c(DrugA,DrugB))
```

Exploratory analysis of the data:

```{r}
ggplot(data=Alpelisib_Trametinib_combination,aes(x=(CONC),y=Viable.cells,col=factor(CONC2)))+
  geom_point(size=1.5)+
  xlab(paste0("[",DrugA,"] (µM)"))+scale_colour_discrete(name=paste0("[",DrugB,"] (µM)"))+
  theme_classic()+
  theme(text = element_text(size=14))
```
BT-20 cells sensitive to both drugs were defined as type 0 cells, whereas cells resistant to trametinib and dactolisib were defined as type 1 and type 2 cells respectively. 

# Dynamics of sensitive cells:

##Calculate net growth rate
Calculate the net growth rates of the BT-20 cell type for every concentration of the two drugs. Use the **net_growth_rate** function for this purpose, where an exponential growth function is assumed to calculate those rates.
```{r}
growth_data<-net_growth_rate(Alpelisib_Trametinib_combination)
head(growth_data)
```
Plot the results:
```{r}
ggplot(data=growth_data,aes(x=(CONC),y=Net_growth,col=factor(CONC2)))+geom_point()+geom_line(linetype="dashed")+
  theme(text = element_text(size=14))+xlab(paste0("[",DrugA,"] (µM)"))+
  scale_colour_discrete(name=paste0("[",DrugB,"] (µM)"))+
  theme_classic()+ylab("Net growth (1/h)")+theme(text = element_text(size=14))
```
## Calculate birth and death rates
As in the LINCS database there is no information regarding apoptosis assays available to estimate the death rate of type 0 cells (d0) and assuming that these targeted therapies do not induce cell death per se, a different d0 value was defined for each combination of the drugs, which was equal to the minimum value needed to ensure that all the birth rates of type 0 cells (b0) were positive regardless of the treatment conditions:
```{r}
d0=vector("list", length = length(unique(growth_data$Cell.line)))
names(d0)=unique(as.character(growth_data$Cell.line))
d0[[1]]=-min(growth_data$Net_growth)
d0
```
We use the **net_growth_rate** function again, to not only calculate the net growth rate parameter of the cells but also the birth and death rates:
```{r}
growth_data<-net_growth_rate(growth_data,death_rate = d0)
ggplot(data=growth_data,aes(x=(CONC),y=Birth_rate,col=factor(CONC2)))+geom_point()+geom_line(linetype="dashed")+
  theme(text = element_text(size=14))+xlab(paste0("[",DrugA,"] (µM)"))+
  scale_colour_discrete(paste0("[",DrugB,"] (µM)"))+
  theme_classic()+ylab("Birth rate of \n sensitive cells, b0 (1/h)")+theme(text = element_text(size=14))

```
Another plot type to analyze the response surface of the data:
```{r}
#We are going to remove the columns that are not necessary for the analysis of the data in this example:
GD=growth_data[,c('Cell.line','CONC','CONC2','Net_growth','Type','Birth_rate','Death_rate')]
GD=unique(GD)
```
Use **responseMap** function to reorganize the data to easily plot the surface of the birth rate values versus for both drug concentrations:
```{r}
rmap <- responseMap(Birth_rate~CONC+CONC2,GD,logscale=T,interpolate=FALSE)
DifferenceSurface.plot(rmap,zcenter=max(growth_data$Birth_rate)/2,
                       xl=paste0("[",DrugA,"] (µM)"),
                       yl=paste0("[",DrugB,"] (µM)"),
                       zl="Birth rate of \n sensitive cells, b0 (1/h)",
                       mid="yellow",low="hotpink1",high="darkturquoise")

```
Use **responseMap** again and **plot.ResponseSurface** to make a contour plot of the data. For this plot a interpolation of the data is needed (see logscale=T in the **responseMap** function):
```{r}
rmap <- responseMap(Birth_rate~CONC+CONC2,GD,logscale=T)

ResponseSurface.plot(rmap,xl=paste0("[",DrugA,"] (µM)"),
                     yl=paste0("[",DrugB,"] (µM)"),
                     zl="Birth rate of \n sensitive cells, b0 (1/h)",
                     palette=c("hotpink1","yellow","darkturquoise"))

```
## Sensitive cell model fitting
Birth rate parameters were fitted nonparametrically using a Generalized Additive Model (GAM) to generate the predicted surface required for the simulation of the evolutionary process:
```{r}
gam.model=Multiple.resp.surface.fit(GD, title=", GAM",Drug1.name=paste0("[",DrugA,"] (µM)"),Drug2.name=paste0("[",DrugB,"] (µM)"))
```

## Dynamics of resistant cells:

Let's start analyzing the dynamics of dactolisib sensitive/ trametinib resistant cell type (Type 1).
```{r}
 data(Alpelisib_sensitive)
 head(Alpelisib_sensitive)
 ggplot(data=Alpelisib_sensitive,aes(x=CONC,y=Birth_rate))+geom_point()+theme_bw()

```
Fit the birth rates with the **Multiple.best.singlefit** function:
```{r}
B1=Multiple.best.singlefit(data=Alpelisib_sensitive.data,resp='Birth_rate')
B1
```
The best function is a expontenial decay model (named EXD.3) with an upper limit of 0.023 1/h, a lower limit of 0.0126 1/h and a steepness of decay of 3.047 µM.

Now, we will repeat this process for the trametinib sensitive/dactolisib resistant cell type (Type 2).

```{r}
 data(Trametinib_sensitive)
 head(Trametinib_sensitive)
 ggplot(data=Trametinib_sensitive,aes(x=CONC2,y=Birth_rate))+geom_point()+theme_bw()

```

Fit the birth rates with the **Multiple.best.singlefit** function:
```{r}
B2=Multiple.best.singlefit(data=Trametinib_sensitive,resp='Birth_rate',conc = "CONC2")
B2
```

## Define drug pharmacokinetic model:
The pharmacokinetic model defined for alpelisib is based on the model from De Buck et al. 2014, whereas for trametinib we used the model defined in Ouellet et al. 2016.
```{r}
#Alpelisib
cmt1_oral<- mread("1cmt_ev", model_library())%>% Req(CP) 
#Trametinib: 
cmt2_oral<- mread("2cmt_ev", model_library())%>% Req(CP)
see(cmt1_oral)
```
Simulate the drug concentration profile for trametinib when a 2mg dose is given every day for a month:
```{r}
e2 <- ev(amt = 2, time=0, ii=1, addl=30)
easy.mrgsim(model=cmt2_oral,dosing_schedule=e2,delta=0.1,tend=30,parameters = list(TVCL=4.91*24,TVV=214,TVKA=2.05*24,Vp=568,Q=60*24),scale=1000/615.4) %>% plot(scales=list(cex=1.5))
```
## Define all the cell types:
We define a inial number of 10^6 sensitive cells and 1000 resistant cells o each type and a mutation rate of 10^-7.
```{r}
Type0 <-define.Type0.cells(N0=10^6,birth_rate = 'gam.model[[1]]',death_rate= 0.03,scale=24,pk.function = c('pk1','pk2'))

Type1 <-define.Typei.cells(Ni=1000,birth_rate = 'B1[[1]]',death_rate  = 0.015,mutation_rate=10^-7,scale=24,pk.function='pk1')

Type2 <-define.Typei.cells(Ni=1000,birth_rate = 'B2[[1]]',death_rate  = 0.01,mutation_rate=10^-7,scale=24,pk.function='pk2')
```

### Simulate the number of sensitive and resistant cells over time:
Fist define the dosing schedules for each drug:
```{r}
#Alpelisib: 300mg/day
e1 <- ev(amt = 300, ii = 1, addl = 60, time=0)
pk1=pk.function(model=cmt1_oral,dosing_schedule=e1,tend=50,parameters = list(TVCL=11.5*24,TVV=118,TVKA=0.784*24,ALAG=0.489/24),scale=1000/441.47) 

#Trametinib: 2mg/day
e2 <- ev(amt = 2, time=0, ii=1, addl=60)
pk2=pk.function(model=cmt2_oral,dosing_schedule=e2,tend=50,parameters = list(TVCL=4.91*24,TVV=214,TVKA=2.05*24,Vp=568,Q=60*24),scale=1000/615.4) 
```
Calculate the number of sensitive cells after a week of treatment:
```{r}
EN_type0_cells(t=7,type_0=Type0,ui=c(Type1@ui,Type2@ui))
```

```{r, eval=FALSE}
En_resistant_cells(N=2,t=7,type_0=Type0,type_i=list(Type1,Type2))
```